Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster Lantus launched today in the US.

US pharma major Eli Lilly today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase III clinical trials ...

An experimental once-weekly insulin known as efsitora has shown comparable effectiveness to daily insulin regimens in ...

The first copycat Lantus – Eli Lilly/Boehringer Ingelheim's Basaglar – was approved in the US in 2017, but that was approved as under a new drug application, not as a biosimilar, and so also ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

See the latest Eli Lilly and Co stock price (LLY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Actor and comedian Nick Kroll is best known for his role on Big Mouth and his Comedy Central series, Kroll Show. He met his wife, Lily Kwong, in 2018 and the two tied the knot in 2020.

Read about Eli Lilly and Co (LLY:XNYS) stock and today's latest news and financial updates.